These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16374520)

  • 21. Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.
    Qi Y; Xu Z; Zhu Q; Thomas C; Kumar R; Feng H; Dostal DE; White MF; Baker KM; Guo S
    Diabetes; 2013 Nov; 62(11):3887-900. PubMed ID: 24159000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport.
    Thirone AC; Huang C; Klip A
    Trends Endocrinol Metab; 2006 Mar; 17(2):72-8. PubMed ID: 16458527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
    Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
    Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
    Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
    Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pdx1 restores beta cell function in Irs2 knockout mice.
    Kushner JA; Ye J; Schubert M; Burks DJ; Dow MA; Flint CL; Dutta S; Wright CV; Montminy MR; White MF
    J Clin Invest; 2002 May; 109(9):1193-201. PubMed ID: 11994408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.
    Li L; Qi X; Williams M; Shi Y; Keegan AD
    J Immunol; 2002 Jun; 168(12):6215-23. PubMed ID: 12055235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
    Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
    J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin receptor substrate proteins and diabetes.
    Lee YH; White MF
    Arch Pharm Res; 2004 Apr; 27(4):361-70. PubMed ID: 15180298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
    Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
    Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice.
    Kushner JA; Haj FG; Klaman LD; Dow MA; Kahn BB; Neel BG; White MF
    Diabetes; 2004 Jan; 53(1):61-6. PubMed ID: 14693698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
    Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption.
    Zheng Y; Yamada H; Sakamoto K; Horita S; Kunimi M; Endo Y; Li Y; Tobe K; Terauchi Y; Kadowaki T; Seki G; Fujita T
    J Am Soc Nephrol; 2005 Aug; 16(8):2288-95. PubMed ID: 15975995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.
    Stöhr O; Tao R; Miao J; Copps KD; White MF
    Cell Rep; 2021 Mar; 34(12):108893. PubMed ID: 33761350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells.
    Yi X; Schubert M; Peachey NS; Suzuma K; Burks DJ; Kushner JA; Suzuma I; Cahill C; Flint CL; Dow MA; Leshan RL; King GL; White MF
    J Neurosci; 2005 Feb; 25(5):1240-8. PubMed ID: 15689562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
    Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
    Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus.
    Kubota N; Terauchi Y; Tobe K; Yano W; Suzuki R; Ueki K; Takamoto I; Satoh H; Maki T; Kubota T; Moroi M; Okada-Iwabu M; Ezaki O; Nagai R; Ueta Y; Kadowaki T; Noda T
    J Clin Invest; 2004 Oct; 114(7):917-27. PubMed ID: 15467830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Mig-6 in hepatic glucose metabolism.
    Yoo JY; Kim TH; Kong S; Lee JH; Choi W; Kim KS; Kim HJ; Jeong JW; Ku BJ
    J Diabetes; 2016 Jan; 8(1):86-97. PubMed ID: 25594850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
    Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice.
    Suzuki R; Tobe K; Aoyama M; Inoue A; Sakamoto K; Yamauchi T; Kamon J; Kubota N; Terauchi Y; Yoshimatsu H; Matsuhisa M; Nagasaka S; Ogata H; Tokuyama K; Nagai R; Kadowaki T
    J Biol Chem; 2004 Jun; 279(24):25039-49. PubMed ID: 15028732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
    Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.